<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Future Growth? Q222 Extremities Market Recap

By Lisa Mahan on 9/15/22 9:30 AM

A variety of conditions decelerated Extremities Market growth, but new product introductions should accelerate future growth 

Companies across the Extremities space reported a variety of conditions decelerating growth in Q222, including supply chain challenges, elective procedure cancellations due to COVID, facility staffing issues and reduced demand for trauma-related devices. WW Extremities Market growth slowed sequentially in Q222 compared to Q122. The US Extremities Market also saw slowing sequential growth. Moving forward, SmartTRAK  expects Extremities market growth to accelerate as headwinds lessen and new product introductions boost revenue.
 

Among the many topics covered in detail in our comprehensive Q222 Extremities Market Recap* are:

Continue Reading
2 min read

New Product Offerings in a Busy Quarter: Q122 Extremities Market Recap

By Lisa Mahan on 6/24/22 9:27 AM

The return of elective procedure volumes, new product offerings and a busy first quarter of acquisitions all supported healthy growth for the Extremities Market

While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players. Stryker*, the Extremities Market leader, benefited from the return of elective procedures in the US. Its US Foot & Ankle and Upper Extremities business segments contributed to the Company’s US Trauma & Extremities growth during the quarter. Stryker also noted during its earnings call that ...

Among the many topics covered in detail in our comprehensive Q122 Extremities Market Recap* are:

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles